Filter Results
:
(898)
Show Results For
-
All HBS Web
(1,283)
- People (5)
- News (165)
- Research (898)
- Events (6)
- Multimedia (12)
- Faculty Publications (735)
Show Results For
-
All HBS Web
(1,283)
- People (5)
- News (165)
- Research (898)
- Events (6)
- Multimedia (12)
- Faculty Publications (735)
Sort by
- February 2001
- Teaching Note
CVS: The Web Strategy TN
By: John A. Deighton
Teaching Note for (9-500-008).
View Details
- 29 Jan 2013
- First Look
First Look: Jan. 29
facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its...
View Details
Keywords:
Sean Silverthorne
- 2016
- Book
Consumers, Corporations, and Public Health: A Case-Based Approach to Sustainable Business
By: John A. Quelch
The public health footprint associated with corporate behavior has come under increased scrutiny in the last decade, with an increased expectation that private profit not come at the expense of consumer welfare.
Consumers, Corporations, and Public... View Details
Consumers, Corporations, and Public... View Details
Keywords:
Consumer;
Corporate Culture;
Public Health;
Consumer Behavior;
Marketing Strategy;
Corporate Strategy;
Health;
Innovation and Invention;
Innovation and Management;
Supply Chain Management;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Asia;
Oceania;
North and Central America;
Middle East;
Latin America;
Europe
Quelch, John A. Consumers, Corporations, and Public Health: A Case-Based Approach to Sustainable Business. New York: Oxford University Press, 2016.
- May 25, 2016
- Comment
How Consumers and Businesses are Reshaping Public Health
By: John A. Quelch
Healthcare and education are two issues in which citizens around the world, rich and poor, are passionately interested. It has long been appreciated that the way that a society treats its youngest and oldest members says much about its moral maturity. Economic...
View Details
Keywords:
Healthcare;
Consumer Power;
Innovation In Healthcare Delivery;
Mobile Healthcare;
Transition;
Transformation;
Trends;
Customer Satisfaction;
Customer Value and Value Chain;
Health Care and Treatment;
Information;
Collaborative Innovation and Invention;
Independent Innovation and Invention;
Innovation and Management;
Innovation Leadership;
Management;
Marketing;
Markets;
Planning;
Problems and Challenges;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
South America;
North and Central America;
Middle East;
Europe;
Asia
Quelch, John A. "How Consumers and Businesses are Reshaping Public Health." Harvard Business School Working Knowledge (May 25, 2016).
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
its 150th anniversary? Purchase this case:https://cb.hbsp.harvard.edu/cbmp/product/319046-PDF-ENG Harvard Business School Case 318-005 Dr. William Carson—Intrapreneurial Innovation in the Pharmaceutical Industry Dr. William Carson, an...
View Details
Keywords:
Dina Gerdeman
- 2018
- Working Paper
Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices
By: Prithwiraj Choudhury and Tarun Khanna
We exploit a natural experiment to study how codifying information about prior innovation affects subsequent innovation. A codified database of traditional Indian herbal formulations was adopted by the European Patent Office (EPO) and the U.S. Patent and Trademark...
View Details
Keywords:
Patents;
Plant-Based Agribusiness;
Ethnicity;
Health Care and Treatment;
Pharmaceutical Industry;
Pharmaceutical Industry;
China;
India
Choudhury, Prithwiraj, and Tarun Khanna. "Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices." Harvard Business School Working Paper, No. 14-079, February 2014. (Revised January 2018.)
- December 2010 (Revised April 2012)
- Background Note
Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round
By: Arthur A. Daemmrich
This note analyzes disputes over intellectual property enforcement and agricultural trade barriers at the center of the Doha Round of World Trade Organization (WTO) negotiations. Fundamental principles of intellectual property rights and agricultural subsidies are...
View Details
Keywords:
Agribusiness;
Trade;
Globalization;
Governance;
International Relations;
Intellectual Property;
Agreements and Arrangements;
Pharmaceutical Industry;
Pharmaceutical Industry
Daemmrich, Arthur A. "Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round." Harvard Business School Background Note 711-043, December 2010. (Revised April 2012.)
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in...
View Details
Keywords:
Martha Lagace
- 26 Jan 2009
- Research & Ideas
Where is Home for the Global Firm?
you share these ideas? A: Of course, once you write something like this, you come to see many things through these lenses. As reported in the Financial Times in October, several UK firms including Shire Pharmaceuticals and WPP Group have...
View Details
Keywords:
by Martha Lagace
- 2011
- Article
Strategic Change and the Jazz Mindset: Exploring Practices That Enhance Dynamic Capabilities for Organizational Improvisation
By: Ethan S. Bernstein and Frank J. Barrett
How can leaders adopt a mindset that maximizes learning, remains responsive to short-term emergent opportunities, and simultaneously strengthens longer-term dynamic capabilities of the organization? This chapter explores the organizational decisions and practices...
View Details
Keywords:
Dynamic Capabilities;
Strategic Change;
Jazz;
Jazz Mindset;
Improvisation;
Innovation;
Change Management;
Collaborative Innovation and Invention;
Innovation and Management;
Innovation Leadership;
Knowledge Use and Leverage;
Leading Change;
Leadership Style;
Leadership;
Management;
Management Style;
Organizational Change and Adaptation;
Organizational Culture;
Organizations;
Creativity;
Strategy;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
United States;
Japan;
Taiwan;
Europe;
Asia
Bernstein, Ethan S., and Frank J. Barrett. "Strategic Change and the Jazz Mindset: Exploring Practices That Enhance Dynamic Capabilities for Organizational Improvisation." Research in Organizational Change and Development 19 (2011): 55–90.
- September 2003 (Revised February 2007)
- Case
PolyMedica Corporation (A)
By: David F. Hawkins and Jacob Cohen
The Securities and Exchange Commission and investors question PolyMedica Corp.'s practice of capitalizing rather than expensing of direct-response advertising.
View Details
Keywords:
Activity Based Costing and Management;
Business Earnings;
Advertising;
Private Sector;
Budgets and Budgeting;
Cost Management;
Capital Markets;
Marketing;
Private Equity;
Pharmaceutical Industry;
Pharmaceutical Industry
Hawkins, David F., and Jacob Cohen. "PolyMedica Corporation (A)." Harvard Business School Case 104-023, September 2003. (Revised February 2007.)
- 2022
- Book
Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]
By: Sabine Pitteloud
En décembre 2020, les Suisses votaient sur l’initiative populaire « pour des multinationales responsables ». Cet épisode récent a rappelé que la régulation de l’activité des sociétés multinationales fait l’objet de luttes politiques, auxquelles participent les...
View Details
Keywords:
Multinational Enterprise;
Multinational Companies;
Multinational Corporations;
Lobbying;
Business & Government Relations;
Labor Relations;
Relocation;
Offshoring And Outsourcing;
Corporate Regulation;
Transnational Regulation;
Multinational Firms and Management;
Business and Government Relations;
Governing Rules, Regulations, and Reforms;
International Relations;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Switzerland
Pitteloud, Sabine. Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]. Genève, Suisse: Librairie Droz, 2022, French ed.
- 02 Apr 2013
- First Look
First Look: April 2
care needs to go "beyond the pill" and systematically integrate combinations of treatments. We discuss the implications of this approach for organizational and business models in the pharmaceutical industry. 2006 World Politics...
View Details
Keywords:
Sean Silverthorne
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is...
View Details
- 09 Jan 2007
- First Look
First Look: January 9, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ...
View Details
Keywords:
Martha Lagace
- 05 Aug 2014
- First Look
First Look: August 5
Case 614-063 Merrimack Pharmaceuticals, Inc. (A) In 2006, Merrimack Pharmaceuticals was a fast-growing biotechnology company. Its leadership team was divided over whether to keep R&D organized in functional departments or transition...
View Details
Keywords:
Sean Silverthorne
- March 2015
- Teaching Note
CVS Health: Promoting Drug Adherence
Email mking@hbs.edu for a courtesy copy.
This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
Keywords:
Medication Adherence;
Affordable Care Act (ACA);
Marketing Strategy;
Communication Strategy;
Customer Value and Value Chain;
Decisions;
Health Care and Treatment;
Goals and Objectives;
Resource Allocation;
Marketing Communications;
Consumer Behavior;
Measurement and Metrics;
Service Delivery;
Behavior;
Motivation and Incentives;
Social Issues;
Information Technology;
Value Creation;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
United States
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Teaching Note 515-086, March 2015. (Email mking@hbs.edu for a courtesy copy.)
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into 16 distinct business units ranging from animal health to oncology while...
View Details
Keywords:
Carmen Nobel
- January 2017 (Revised March 2017)
- Case
Royal DSM: From Continuous Transformation to Organic Growth
By: William W. George, Carin-Isabel Knoop and Amram Migdal
Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s...
View Details
Keywords:
Organic Growth;
Organizational Change;
M&A;
Mergers And Acquisitions;
Divestment;
Business Ventures;
Business Divisions;
Business Growth and Maturation;
Restructuring;
Change;
Change Management;
Transformation;
Transition;
Engineering;
Chemicals;
Mining;
Ethics;
Values and Beliefs;
Finance;
Capital Markets;
Financial Markets;
Food;
Globalization;
Global Strategy;
Globalized Firms and Management;
Globalized Markets and Industries;
Health;
Nutrition;
History;
Leadership;
Leadership Development;
Leadership Style;
Leading Change;
Management;
Business or Company Management;
Growth and Development Strategy;
Growth Management;
Management Practices and Processes;
Management Style;
Organizations;
Corporate Social Responsibility and Impact;
Mission and Purpose;
Organizational Change and Adaptation;
Organizational Culture;
Organizational Design;
Ownership;
Public Ownership;
Performance;
Strategy;
Adaptation;
Consolidation;
Corporate Strategy;
Value;
Value Creation;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Europe;
Netherlands
George, William W., Carin-Isabel Knoop, and Amram Migdal. "Royal DSM: From Continuous Transformation to Organic Growth." Harvard Business School Case 317-063, January 2017. (Revised March 2017.)
- 05 Sep 2007
- First Look
First Look: September 5, 2007
value, or derail deals altogether. Consider, for example, the pharmaceutical company that deadlocked with a supplier over the issue of exclusivity in an ingredient purchase. Believing it was a ploy to raise the price, the drug maker upped...
View Details
Keywords:
Martha Lagace